Frontiers of lung cancer screening
Joint sessionChairs: R. Gosens (Groningen, Netherlands), O. Burghuber (Wien, Austria)
Aims: Please note that this session is not CME accredited.
To present cost-effectiveness of lung cancer screening with CT-scan; to discuss the role of artificial intelligence in lung cancer screening; to assess risks and advantages of radiation therapy and the possible effects (radiation injury, second primary cancer)
This session is made possible thanks to the financial support of the following companies:
AstraZeneca,
F. Hoffmann - La Roche &
Siemens Healthineers